HLB Pharma
- Korea's Second-Quarter Earnings Show a Broad but Uneven Profit Recovery
Q2 results from Dongbu E&C, HiteJinro, HLB Pharma and Stonebridge Ventures point to a profit recovery spreading across Korea's mid-cap economy.
Q2 results from Dongbu E&C, HiteJinro, HLB Pharma and Stonebridge Ventures point to a profit recovery spreading across Korea's mid-cap economy.
